MX2024001867A - Vacuna de particulas similares a virus para el virus respiratorio sincitial. - Google Patents
Vacuna de particulas similares a virus para el virus respiratorio sincitial.Info
- Publication number
- MX2024001867A MX2024001867A MX2024001867A MX2024001867A MX2024001867A MX 2024001867 A MX2024001867 A MX 2024001867A MX 2024001867 A MX2024001867 A MX 2024001867A MX 2024001867 A MX2024001867 A MX 2024001867A MX 2024001867 A MX2024001867 A MX 2024001867A
- Authority
- MX
- Mexico
- Prior art keywords
- virus
- respiratory syncytial
- particle vaccine
- syncytial virus
- rsv
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/155—Paramyxoviridae, e.g. parainfluenza virus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
- A61K2039/5258—Virus-like particles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/545—Medicinal preparations containing antigens or antibodies characterised by the dose, timing or administration schedule
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55505—Inorganic adjuvants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55566—Emulsions, e.g. Freund's adjuvant, MF59
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/57—Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2
- A61K2039/575—Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2 humoral response
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/70—Multivalent vaccine
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/18011—Paramyxoviridae
- C12N2760/18511—Pneumovirus, e.g. human respiratory syncytial virus
- C12N2760/18522—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/18011—Paramyxoviridae
- C12N2760/18511—Pneumovirus, e.g. human respiratory syncytial virus
- C12N2760/18523—Virus like particles [VLP]
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/18011—Paramyxoviridae
- C12N2760/18511—Pneumovirus, e.g. human respiratory syncytial virus
- C12N2760/18534—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Virology (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Genetics & Genomics (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Molecular Biology (AREA)
- Microbiology (AREA)
- Immunology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biochemistry (AREA)
- Engineering & Computer Science (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Communicable Diseases (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Mycology (AREA)
- Oncology (AREA)
- Epidemiology (AREA)
- Biotechnology (AREA)
- Biomedical Technology (AREA)
- General Engineering & Computer Science (AREA)
- Gastroenterology & Hepatology (AREA)
- Biophysics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Pulmonology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163231568P | 2021-08-10 | 2021-08-10 | |
| US202263367103P | 2022-06-27 | 2022-06-27 | |
| PCT/US2022/074699 WO2023019131A1 (en) | 2021-08-10 | 2022-08-09 | Virus-like particle vaccine for respiratory syncytial virus |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MX2024001867A true MX2024001867A (es) | 2024-03-04 |
Family
ID=85200421
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2024001867A MX2024001867A (es) | 2021-08-10 | 2022-08-09 | Vacuna de particulas similares a virus para el virus respiratorio sincitial. |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US20240350616A1 (https=) |
| EP (1) | EP4384535A4 (https=) |
| JP (1) | JP2024531150A (https=) |
| KR (1) | KR20240046885A (https=) |
| AU (1) | AU2022326546A1 (https=) |
| CA (1) | CA3228461A1 (https=) |
| IL (1) | IL310628A (https=) |
| MX (1) | MX2024001867A (https=) |
| WO (1) | WO2023019131A1 (https=) |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP5762408B2 (ja) * | 2009-08-13 | 2015-08-12 | クルセル ホランド ベー ヴェー | ヒト呼吸器合胞体ウイルス（ｒｓｖ）に対する抗体および使用方法 |
| EP2970398B1 (en) * | 2013-03-13 | 2024-05-08 | The United States of America, as Represented by The Secretary, Department of Health and Human Services | Prefusion rsv f proteins and their use |
| HUE073526T2 (hu) * | 2017-04-04 | 2026-01-28 | Univ Washington | Önmagát összeállító fehérje nanostruktúrák, amelyek paramyxovírus és/vagy pneumovírus F fehérjéket jelenítenek meg és azok használata |
| US11376317B2 (en) * | 2017-08-30 | 2022-07-05 | University Of Maryland, College Park | FcRn-targeted mucosal vaccination against RSV |
-
2022
- 2022-08-09 IL IL310628A patent/IL310628A/en unknown
- 2022-08-09 KR KR1020247007829A patent/KR20240046885A/ko active Pending
- 2022-08-09 CA CA3228461A patent/CA3228461A1/en active Pending
- 2022-08-09 AU AU2022326546A patent/AU2022326546A1/en active Pending
- 2022-08-09 MX MX2024001867A patent/MX2024001867A/es unknown
- 2022-08-09 WO PCT/US2022/074699 patent/WO2023019131A1/en not_active Ceased
- 2022-08-09 US US18/682,281 patent/US20240350616A1/en active Pending
- 2022-08-09 EP EP22856762.4A patent/EP4384535A4/en active Pending
- 2022-08-09 JP JP2024508009A patent/JP2024531150A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| IL310628A (en) | 2024-04-01 |
| EP4384535A1 (en) | 2024-06-19 |
| EP4384535A4 (en) | 2025-06-25 |
| AU2022326546A1 (en) | 2024-02-15 |
| WO2023019131A1 (en) | 2023-02-16 |
| KR20240046885A (ko) | 2024-04-11 |
| US20240350616A1 (en) | 2024-10-24 |
| JP2024531150A (ja) | 2024-08-29 |
| CA3228461A1 (en) | 2023-02-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MX2020010941A (es) | Moleculas y composiciones novedosas de arn de vsr para vacunacion. | |
| MX2012000035A (es) | Antigenos de virus de sincicio respiratorio recombinantes. | |
| EP4670734A3 (en) | Recombinant rsv antigens | |
| TN2018000154A1 (en) | Respiratory syncytial virus vaccine | |
| WO2017040387A3 (en) | Human respiratory syncytial virus (hrsv) virus-like particles (vlps) based vaccine | |
| MX337932B (es) | Proteinas f del vrs modificadas y metodos de uso de las mismas. | |
| CA2817005A1 (en) | Rabies glycoprotein virus-like particles (vlps) | |
| WO2008061243A3 (en) | Respiratory syncytial virus-virus like particle (vlps) | |
| MX2019003682A (es) | Antigenos de consenso del virus sincitial respiratorio humano, constructos de acido nucleico y vacunas hechas de estos, y metodos para utilizarlas. | |
| TN2011000182A1 (en) | Live, attentuated respiratory syncytial virus | |
| WO2009042794A3 (en) | Venezuelan equine encephalitis replicons expressing paramyxovirus glycoproteins as vaccine | |
| MX2009006178A (es) | Vacuna contra salmonela. | |
| WO2013006569A3 (en) | Herpes virus vaccine and methods of use | |
| MX2018015506A (es) | Vacuna contra virus de bronquitis infecciosa. | |
| WO2012037078A3 (en) | Immunogenic respiratory syncytial virus glycoprotein-containing vlps and related compositions, constructs, and therapeutic methods | |
| WO2024191860A3 (en) | Nucleic acid influenza vaccines and respiratory virus combination vaccines | |
| MX2025005156A (es) | Vacuna de arn contra el virus respiratorio sincicial | |
| UA110505C2 (ru) | Імуногенні композиції bordetella bronchiseptica | |
| PH12018501750A1 (en) | Porcine reproductive and respiratory syndrome vaccine virus | |
| MX2024001867A (es) | Vacuna de particulas similares a virus para el virus respiratorio sincitial. | |
| RU2015125313A (ru) | Вакцина для защиты жвачных животных от пневмонии, вызываемой pasteurella multocida | |
| JP2015519367A5 (https=) | ||
| WO2011100234A3 (en) | Immunogenic hpv l2-containing vlps and related compositions, constructs, and therapeutic methods | |
| WO2011154976A3 (en) | Improved influenza vaccine | |
| MX2024002621A (es) | Partículas similares a virus para el tratamiento o prevención de una infección por un virus coronaviridae. |